These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8488077)

  • 1. Porphobilinogen deaminase activity in malignant proliferative disorders of the lymphatic system and bone marrow.
    Zawirska B; Usnarska-Zubkiewicz L; Gamian E
    Patol Pol; 1993; 44(1):13-7. PubMed ID: 8488077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte porphobilinogen deaminase activity in liver diseases and proliferative diseases of the haemopoietic system and lymph nodes.
    Ostrowski J; Lutyński A; Cianciara J; Martyńska M; Kostrzewska E; Butruk E
    Mater Med Pol; 1987; 19(4):234-7. PubMed ID: 3454831
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adenosine deaminase activity in hemoblastoses].
    Krüger W; Müller G; Storch H; Kubel M; Richter V
    Arch Geschwulstforsch; 1983; 53(1):53-9. PubMed ID: 6574729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased porphobilinogen deaminase activity in patients with malignant lymphoproliferative diseases. A helpful diagnostic test.
    Lahav M; Epstein O; Schoenfeld N; Shaklai M; Atsmon A
    JAMA; 1987 Jan; 257(1):39-42. PubMed ID: 3783901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of abnormality of lymphocyte uroporphyrinogen synthase in family members of patients with lymphoproliferative diseases.
    Lahav M; Epstein O; Schoenfeld N; Nemesh L; Shaklai M; Atsmon A
    Cancer Lett; 1985 Jan; 25(3):305-10. PubMed ID: 3971346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The glutathione enzymatic redox system in the blood of patients with lymphoproliferative diseases].
    Gavriliuk LA; Shraĭman ML
    Vopr Onkol; 1992; 38(11):1304-8. PubMed ID: 1343159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haem precursors and porphobilinogen deaminase in erythrocytes and lymphocytes of patients with acute intermittent porphyria.
    Gross U; Jacob K; Frank M; Doss MO
    Cell Mol Biol (Noisy-le-grand); 1997 Feb; 43(1):29-35. PubMed ID: 9074786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in Ca, Mg-dependent endonuclease of DNA in isolated nuclei of human lymphocytes in lymphoproliferative diseases].
    Tkacheva TI; Kirzon SS; Khodarev NN; Botrin II
    Biull Eksp Biol Med; 1990 Jun; 109(6):543-6. PubMed ID: 2397289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymidine kinase isoenzymes in human malignant lymphoma.
    Ellims PH; Van der Weyden MB; Medley G
    Cancer Res; 1981 Feb; 41(2):691-5. PubMed ID: 7448815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytidine triphosphate synthetase activity in lymphoproliferative disorders.
    Ellims PH; Gan TE; Medley G
    Cancer Res; 1983 Mar; 43(3):1432-5. PubMed ID: 6572096
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of porphobilinogen deaminase analysis in clinical tests].
    Sassa S
    Nihon Rinsho; 1989 Dec; 48 Suppl():711-4. PubMed ID: 2621989
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acid nonspecific esterase in lymphoproliferative conditions].
    Hermanský F; Benesová E; Lodrová V; Sálková J
    Vnitr Lek; 1979 May; 25(5):436-42. PubMed ID: 452428
    [No Abstract]   [Full Text] [Related]  

  • 14. [Porphobilinogen synthase activity of the erythrocytes in acute leukemia].
    Arsov Ts; Ivanov E; Gekova K
    Vutr Boles; 1981; 20(4):106-11. PubMed ID: 6946639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiles and prognostic values of serum LDH isoenzymes in patients with haematopoietic malignancies.
    Bouafia F; Drai J; Bienvenu J; Thieblemont C; Espinouse D; Salles G; Coiffier B
    Bull Cancer; 2004; 91(7-8):E229-40. PubMed ID: 15381461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of tartrate-resistant acid phosphatase activity in lymphoma cells of the bone marrow].
    Mariańska B; Maj S; Apel D
    Acta Haematol Pol; 1985; 16(3-4):122-6. PubMed ID: 3835768
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
    Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
    Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The regulation of porphobilinogen oxygenase and porphobilinogen deaminase activities in rat bone marrow under conditions of erythropoietic stress.
    Frydman RB; Tomaro ML; Sburlati A; Gutnisky A
    Biochim Biophys Acta; 1986 Apr; 870(3):520-9. PubMed ID: 3697363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysteamine S-phosphate hydrolysis by pure human alkaline phosphatases and by sera from patients with lymphoproliferative disorders.
    Gainer AL; Stinson RA
    Cancer Res; 1982 Sep; 42(9):3507-9. PubMed ID: 7105027
    [No Abstract]   [Full Text] [Related]  

  • 20. Kinetic and molecular parameters of human hepatic porphobilinogen deaminase.
    Mazzetti MB; Tomio JM
    Biochem Int; 1990; 21(3):463-71. PubMed ID: 2222491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.